2016
DOI: 10.1016/j.antiviral.2016.04.001
|View full text |Cite
|
Sign up to set email alerts
|

Selection of therapeutic H5N1 monoclonal antibodies following IgVH repertoire analysis in mice

Abstract: The rapid rate of influenza virus mutation drives the emergence of new strains that inflict serious seasonal epidemics and less frequent, but more deadly, pandemics. While vaccination provides the best protection against influenza, its utility is often diminished by the unpredictability of new pathogenic strains. Consequently, efforts are underway to identify new antiviral drugs and monoclonal antibodies that can be used to treat recently infected individuals and prevent disease in vulnerable populations. Next… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
5
0

Year Published

2017
2017
2019
2019

Publication Types

Select...
5
1

Relationship

1
5

Authors

Journals

citations
Cited by 6 publications
(5 citation statements)
references
References 42 publications
(66 reference statements)
0
5
0
Order By: Relevance
“…It provides a comparative foundation when looking at host response to antigen [ 54 ] and has been used to isolated therapeutic antibodies. Antibodies for influenza in a mouse model and were a valuable tool in the detection of antigen specific responses [ 16 , 34 ].…”
Section: Discussionmentioning
confidence: 99%
“…It provides a comparative foundation when looking at host response to antigen [ 54 ] and has been used to isolated therapeutic antibodies. Antibodies for influenza in a mouse model and were a valuable tool in the detection of antigen specific responses [ 16 , 34 ].…”
Section: Discussionmentioning
confidence: 99%
“…Finally, future work that integrates FACS data with computational sequence analysis may decrease the rate of false positives. Prior computational work has focused on choosing the most frequent binders, 4 , 24-25 , 27 or identifying antibodies shared between replicate mice. 28 Other approaches for future study include computational structural analysis of putative binders and computational methods for detection of affinity maturation.…”
Section: Discussionmentioning
confidence: 99%
“…At 21 days following intramuscular immunization, RNA was prepared from splenocytes of immunized mice ( n = 5/group), and antibody repertoire diversity assessed by deep-sequencing of antibody immunoglobulin heavy chain (IgH) variable (V) regions as previously described. 41 The number of specific IgH V gene sequences induced by each adjuvant was determined across a range of significance scores, defined as the negative log of the e-score cutoff value, which indicate the probability of a given sequence being specific to that adjuvant group. SLA-LSQ induced a larger number of total IgH V-gene sequences (Fig.…”
Section: Resultsmentioning
confidence: 99%
“…Antibody repertoire in splenocytes was assessed by HiSeq analysis of amplified CDR3 sequences as described previously. 41 , 45 Sequences were quantified by identification of unique molecular identifiers (UMI), with specific sequences for each adjuvant determined by calculation of a significance score. The number of specific sequence counts a as well as the number of specific CDR3 sequences b was determined across a range of negative log e-score cutoff values.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation